Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
- February -
March
-
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
- 2015 -
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
February 2015 - 35 products
L
IP
CI
Noxafil 100 mg
24 Tablet(s)
617.34
684.35
10 %
Gastric juice resistant tablets: Posaconazolum 100 mg
MSD Merck Sharp &
Dohme AG
B / SL / SO
FB
G
L
IP
CI
Noxafil 100 mg
96 Tablet(s)
2469.34
2688.15
10 %
Gastric juice resistant tablets: Posaconazolum 100 mg
MSD Merck Sharp &
Dohme AG
B / SL / SO
FB
G
L
IP
CI
Gliclazid-Mepha 60 retard
30 Tablet(s)
7.84
17.75
10 %
Delayed release tablets: Gliclazidum 60 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Gliclazid-Mepha 60 retard
90 Tablet(s)
19.25
37.35
10 %
Delayed release tablets: Gliclazidum 60 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Valganciclovir Sandoz 450 mg
60 Tablet(s)
1054.01
1162.70
10 %
Coated tablets: Valganciclovirum 450 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
CM
Pregabalin Viatris 25 mg
14
3.28
12.80
10 %
Capsules: Pregabalinum 25 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Pregabalin Viatris 25 mg
56
9.27
26.50
10 %
Capsules: Pregabalinum 25 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Pregabalin Viatris 50 mg
14
3.89
13.45
10 %
Capsules: Pregabalinum 50 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Pregabalin Viatris 50 mg
84
20.53
38.75
10 %
Capsules: Pregabalinum 50 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Pregabalin Viatris 75 mg
14
4.53
14.15
10 %
Capsules: Pregabalinum 75 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Pregabalin Viatris 75 mg
56
18.07
36.05
10 %
Capsules: Pregabalinum 75 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Pregabalin Viatris 100 mg
84
23.37
41.80
10 %
Capsules: Pregabalinum 100 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Pregabalin Viatris 150 mg
56
23.37
41.80
10 %
Capsules: Pregabalinum 150 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Pregabalin Viatris 150 mg
168
68.70
91.05
10 %
Capsules: Pregabalinum 150 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Pregabalin Viatris 200 mg
84
30.51
49.55
10 %
Capsules: Pregabalinum 200 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Pregabalin Viatris 300 mg
56
30.51
49.55
10 %
Capsules: Pregabalinum 300 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
CI
CM
Pregabalin Viatris 300 mg
168
89.70
113.90
10 %
Capsules: Pregabalinum 300 mg
Viatris Pharma GmbH
B / SL / SG
FB
G
L
IP
CI
PP
Cosentyx 150 mg / 1 ml
Fertigspritze(n)
538.86
602.45
10 %
Injection solution in prefilled syringe: Secukinumabum 150 mg/ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
PP
Cosentyx 300 mg / 2 ml
1074.57
1185.10
10 %
Injection solution in prefilled syringe: Secukinumabum 300mg / 2ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
PP
Cosentyx 75 mg / 0.5 ml
269.43
309.45
10 %
Injection solution in prefilled syringe: Secukinumabum 75mg / 0.5ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
PP
Cosentyx 150 mg / 1 ml
2 Fertigspritze(n)
1074.57
1185.10
10 %
Injection solution in prefilled syringe: Secukinumabum 150 mg/ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
PP
Cosentyx 150 mg
Durchstechflasche(n)
538.86
602.45
10 %
Dry substance: Secukinumabum 150 mg
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
Tybost 150 mg
30 Tablet(s)
43.19
63.40
10 %
Coated tablets: Cobicistatum 150 mg
Gilead Sciences
Switzerland Sàrl
A / SL
FB
G
L
IP
CI
PP
Cosentyx SensoReady 150 mg / 1 ml
538.86
602.45
10 %
Injektionslösung in Fertigpen: Secukinumabum 150 mg/ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
CI
PP
Cosentyx SensoReady 150 mg / 1 ml
2
1074.57
1185.10
10 %
Injektionslösung in Fertigpen: Secukinumabum 150 mg/ml
Novartis Pharma
Schweiz AG
B / SL
FB
G
L
IP
Entyvio
Durchstechflasche(n)
2177.01
2384.05
10 %
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Vedolizumabum 300 mg
Takeda Pharma AG
A / SL
FB
G
L
IP
CI
PP
Signifor LAR 20 mg
Durchstechflasche(n) à 20 mg
3011.01
3291.05
10 %
Pulver und Lösung zur Herstellung einer Injektionssuspension: Pasireotidum 20 mg
Recordati AG
A / SL
FB
G
L
IP
CI
PP
Signifor LAR 40 mg
Durchstechflasche(n) à 40 mg
3011.01
3291.05
10 %
Pulver und Lösung zur Herstellung einer Injektionssuspension: Pasireotidum 40 mg
Recordati AG
A / SL
FB
G
L
IP
CI
PP
Signifor LAR 60 mg
Durchstechflasche(n) à 60 mg
3011.01
3291.05
10 %
Pulver und Lösung zur Herstellung einer Injektionssuspension: Pasireotidum 60 mg
Recordati AG
A / SL
FB
G
IP
Bocouture 50 LD50-
Einheiten
Durchstechflasche(n)
PR
PR
k.A.
Dry substance: Toxinum Botulinicum a (150 Kda) 50 U
Merz Aesthetics
(Schweiz) AG
A
FB
G
IP
Bocouture 100 LD50-
Einheiten
PR
PR
k.A.
Dry substance: Toxinum Botulinicum a (150 Kda) 100 U
Merz Aesthetics
(Schweiz) AG
A
FB
G
IP
CI
Biotin Merz 5 mg
25 Tablet(s)
PR
PR
k.A.
Tablets: Biotinum 5 mg
Merz Pharma (Schweiz) AG
D
FB
G
IP
CI
Biotin Merz 5 mg
100 Tablet(s)
PR
PR
k.A.
Tablets: Biotinum 5 mg
Merz Pharma (Schweiz) AG
D
FB
G
IP
PP
Signifor LAR 10 mg
10 mg
PR
PR
k.A.
Pulver und Lösung zur Herstellung einer Injektionssuspension: Pasireotidum 10 mg
Recordati AG
A
FB
G
IP
PP
Signifor LAR 30 mg
30 mg
PR
PR
k.A.
Pulver und Lösung zur Herstellung einer Injektionssuspension: Pasireotidum 30 mg
Recordati AG
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home